24.12.2012 Views

section 1 - World Intellectual Property Organization

section 1 - World Intellectual Property Organization

section 1 - World Intellectual Property Organization

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

42/1998<br />

22 Oct/oct 1998 PCT Gazette - Section I - Gazette du PCT 14727<br />

(31) 9/100675 (32) 17 Apr/avr 1997 (33) JP<br />

(17.04.1997)<br />

(31) 10/41495 (32) 24 Feb/fév 1998 (33) JP<br />

(24.02.1998)<br />

(43) 22 Oct/oct 1998 (22.10.1998)<br />

(51) 6 C07D 401/06, A61K 31/55, C07D 413/06,<br />

413/14, 401/14, A61K 31/44, 31/40, C07D<br />

417/14, 405/14, 409/14<br />

(54) • THERMOGENIC COMPOSITION AND BEN-<br />

ZAZEPINE THERMOGENICS<br />

• COMPOSITION THERMOGENIQUE ET<br />

COMPOSES THERMOGENIQUES A BASE<br />

DE BENZAZEPINE<br />

(71) TAKEDA CHEMICAL INDUSTRIES, LTD.<br />

[JP/JP]; 1–1, Doshomachi 4–chome, Chuo–ku,<br />

Osaka–shi, Osaka 541–0045 (JP).<br />

(for all designated States except / pour tous les États<br />

désignés sauf US)<br />

(72, 75) ISHIHARA, Yuji [JP/JP]; 3–8, Yamada<br />

3–chome, Itami–shi, Hyogo 664–0874 (JP).<br />

FUJISAWA, Yukio [JP/JP]; 1–31–104, Mikagenakamachi<br />

4–chome, Higashinada–ku, Kobe–shi,<br />

Hyogo 658–0054 (JP). FURUYAMA, Naoki<br />

[JP/JP]; 6–2, Shinoharadai, Nada–ku, Kobe–shi,<br />

Hyogo 657–0016 (JP).<br />

(74) ASAHINA, Tadao et al. / etc.; Osaka Plant of<br />

Takeda Chemical Industries, Ltd., 17–85, Jusohonmachi<br />

2–chome, Yodogawa–ku, Osaka–shi, Osaka<br />

532–0024 (JP).<br />

(81) AL AM AU AZ BA BB BG BR BY CA CN CU<br />

CZ EE GE GW HU ID IL IS KG KR KZ LC LK<br />

LR LT LV MD MG MK MN MX NO NZ PL RO<br />

RU SG SI SK SL TJ TM TR TT UA US UZ VN<br />

YU; AP (GH GM KE LS MW SD SZ UG ZW);<br />

EA (AM AZ BY KG KZ MD RU TJ TM); EP (AT<br />

BE CH CY DE DK ES FI FR GB GR IE IT LU<br />

MC NL PT SE); OA (BF BJ CF CG CI CM GA<br />

GN ML MR NE SN TD TG).<br />

Published / Publiée : (c)<br />

(11) WO 98/46591 (13) A1<br />

(21) PCT/US98/07158<br />

(22) 13 Apr/avr 1998 (13.04.1998)<br />

(25) en (26) en<br />

(31) 60/069,884 (32) 14 Apr/avr 1997 (33) US<br />

(14.04.1997)<br />

(43) 22 Oct/oct 1998 (22.10.1998)<br />

(51) 6 C07D 401/06, 241/08, 295/20, 417/12, A61K<br />

31/495<br />

(54) • SELECTIVE FACTOR Xa INHIBITORS<br />

• INHIBITEURS SELECTIFS DU FACTEUR Xa<br />

(71) COR THERAPEUTICS, INC. [US/US]; 256 E.<br />

Grand Avenue, South San Francisco, CA 94080<br />

(US).<br />

(72) MARLOWE, Charles, K.; 3691 Brandy<br />

Rock Way, Redwood City, CA 94061 (US).<br />

SCARBOROUGH, Robert, M.; 2544 Belmont<br />

Canyon Road, Belmont, CA 94002 (US). ZHU,<br />

Bing–Yan; Apartment K302, 1125 Balclutha<br />

Drive, Foster City, CA 94404 (US).<br />

(74) ADLER, Reid, G. et al. / etc.; Morgan, Lewis &<br />

Bockius LLP, 1800 M Street, N.W., Washington,<br />

DC 20036 (US).<br />

(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />

CN CU CZ DE DK EE ES FI GB GE GH GM<br />

GW HU ID IL IS JP KE KG KP KR KZ LC LK<br />

LR LS LT LU LV MD MG MK MN MW MX NO<br />

NZ PL PT RO RU SD SE SG SI SK SL TJ TM<br />

TR TT UA UG UZ VN YU ZW; AP (GH GM KE<br />

LS MW SD SZ UG ZW); EA (AM AZ BY KG<br />

KZ MD RU TJ TM); EP (AT BE CH CY DE DK<br />

ES FI FR GB GR IE IT LU MC NL PT SE); OA<br />

(BF BJ CF CG CI CM GA GN ML MR NE SN<br />

TD TG).<br />

(11) WO 98/46592 (13) A1<br />

(21) PCT/EP98/01847<br />

(22) 30 Mar/mar 1998 (30.03.1998)<br />

(25) de (26) de<br />

(31) 197 15 017.9 (32) 11 Apr/avr 1997<br />

(11.04.1997)<br />

(33) DE<br />

(43) 22 Oct/oct 1998 (22.10.1998)<br />

(51) 6 C07D 401/12, 403/12, 405/12, 413/12, 417/12,<br />

A01N 43/54<br />

(54) • SUBSTITUTED ARYLURACILS<br />

• ARYLURACILES SUBSTITUES<br />

(71) BAYER AKTIENGESELLSCHAFT [DE/DE];<br />

D–51368 Leverkusen (DE).<br />

(for all designated States except / pour tous les États<br />

désignés sauf US)<br />

(72, 75) ANDREE, Roland [DE/DE]; Dechant–Miebach–Weg<br />

37, D–40764 Langenfeld<br />

(DE). DOLLINGER, Markus [DE/DE]; Burscheider<br />

Strasse 154b, D–51381 Leverkusen<br />

(DE). ERDELEN, Christoph [DE/DE]; Unterbüscherhof<br />

15, D–42799 Leichlingen (DE).<br />

(74) BAYER AKTIENGESELLSCHAFT; D–51368<br />

Leverkusen (DE).<br />

(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />

CN CU CZ DE DK EE ES FI GB GE GH GM GW<br />

HU ID IL IS JP KE KG KP KR KZ LC LK LR<br />

LS LT LU LV MD MG MK MN MW MX NO NZ<br />

PL PT RO RU SD SE SG SI SK SL TJ TM TR TT<br />

UA UG US UZ VN YU ZW; AP (GH GM KE LS<br />

MW SD SZ UG ZW); EA (AM AZ BY KG KZ<br />

MD RU TJ TM); EP (AT BE CH DE DK ES FI<br />

FR GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />

CF CG CI CM GA GN ML MR NE SN TD TG).<br />

(11) WO 98/46593 (13) A1<br />

(21) PCT/JP98/01726<br />

(22) 15 Apr/avr 1998 (15.04.1998)<br />

(25) en (26) en<br />

(31) 9/98694 (32) 16 Apr/avr 1997<br />

(16.04.1997)<br />

(33) JP<br />

(43) 22 Oct/oct 1998 (22.10.1998)<br />

(51) 6 C07D 401/12, C07H 15/18, A61K 31/47, 31/70<br />

(54) • NOVEL CARBOSTYRIL DERIVATIVE<br />

• NOUVEAU PROCEDE DE CARBOSTYRILE<br />

(71) OTSUKA PHARMACEUTICAL CO., LTD.<br />

[JP/JP]; 2–9, Kanda–Tsukasacho, Chiyoda–ku,<br />

Tokyo 101–0048 (JP).<br />

(for all designated States except / pour tous les États<br />

désignés sauf US)<br />

(72, 75) OHTANI, Tadaaki [JP/JP]; Shandofururu<br />

C–211, 80–2, Aza Inamoto, Nakakirai, Matsushigecho,<br />

Itano–gun, Tokushima 771–0212 (JP).<br />

OTSUBO, Kenji [JP/JP]; Birudo.Nosaido 201, 45,<br />

Kitayasocho 4–chome, Tokushima–shi, Tokushima<br />

770–0006 (JP). MATSUBARA, Jun [JP/JP];<br />

Zeneraru Nezu, 1–1–21, Nezu, Bunkyo–ku, Tokyo<br />

113–0031 (JP). KITANO, Kazuyoshi [JP/JP];<br />

1–53, Aza Nishiyamada, Hinoki, Oasacho, Naruto–shi,<br />

Tokushima 779–0225 (JP). MORITA,<br />

Seiji [JP/JP]; 1076–44, Kagasuno, Kawauchicho,<br />

Tokushima–shi, Tokushima 771–0130 (JP).<br />

KAWANO, Yoshikazu [JP/JP]; 463–30, Kagasuno,<br />

Kawauchicho, Tokushima–shi, Tokushima<br />

771–0130 (JP). UCHIDA, Minoru [JP/JP]; 11,<br />

Aza Honson, Ohayashicho, Komatsushima–shi,<br />

Tokushima 773–0022 (JP). YAMASHITA, Shuji<br />

[JP/JP]; 5–39, Aza Ekokawa, Shinkirai, Kitajimacho,<br />

Itano–gun, Tokushima 771–0207 (JP).<br />

(74) ASAMURA, Kiyoshi et al. / etc.; New Ohtemachi<br />

Building, Room 331, 2–1, Ohtemachi 2–chome,<br />

Chiyoda–ku, Tokyo 100–0004 (JP).<br />

(81) AU BR CA CN ID KR MX SG US; EP (AT BE<br />

CH CY DE DK ES FI FR GB GR IE IT LU MC<br />

NL PT SE).<br />

(11) WO 98/46594 (13) A1<br />

(21) PCT/JP98/01664<br />

(22) 10 Apr/avr 1998 (10.04.1998)<br />

(25) ja (26) ja<br />

(31) 9/108299 (32) 11 Apr/avr 1997 (33) JP<br />

(11.04.1997)<br />

(43) 22 Oct/oct 1998 (22.10.1998)<br />

(51) 6 C07D 403/04, 413/04, 417/04, A61K 31/415,<br />

31/42, 31/425<br />

(54) • PYRAZOLE DERIVATIVES AND COX INHI-<br />

BITORS CONTAINING THEM<br />

• DERIVES DE PYRAZOLE ET INHIBITEURS<br />

DE COX LES RENFERMANT<br />

(71) GRELAN PHARMACEUTICAL CO., LTD.<br />

[JP/JP]; 3–9, Nozawa 3–chome, Setagaya–ku,<br />

Tokyo 154–0003 (JP).<br />

(for all designated States except / pour tous les États<br />

désignés sauf US)<br />

(72, 75) AOTSUKA, Tomoji [JP/JP]; Grelan Research<br />

Center, 4–3, Sakaecho 3–chome, Hamura–shi,<br />

Tokyo 205–0002 (JP). WAGATSUMA, Nagatoshi<br />

[JP/JP]; Grelan Research Center, 4–3, Sakaecho<br />

3–chome, Hamura–shi, Tokyo 205–0002 (JP).<br />

KATO, Hideo [JP/JP]; 26–1–302, Higashiyama<br />

143, Kusamacho, Toyohashi–shi, Aichi 441–8141<br />

(JP). ASHIZAWA, Naoki [JP/JP]; Grelan Research<br />

Center, 4–3, Sakaecho 3–chome, Hamura–shi, Tokyo<br />

205–0002 (JP).<br />

(74) MIZUNO, Akinobu; Gloria Miyamasuzaka III<br />

305, 10–7, Shibuya 1–chome, Shibuya–ku, Tokyo<br />

150–0002 (JP).<br />

(81) JP US; EP (AT BE CH CY DE DK ES FI FR GB<br />

GR IE IT LU MC NL PT SE).<br />

(11) WO 98/46595<br />

(21) PCT/IB98/00540<br />

(13) A1<br />

(22) 9 Apr/avr 1998 (09.04.1998)<br />

(25) en (26) en<br />

(31) 60/042,316 (32) 15 Apr/avr 1997<br />

(15.04.1997)<br />

(33) US<br />

(43) 22 Oct/oct 1998 (22.10.1998)<br />

(51) 6 C07D 403/12, A61K 31/415<br />

(54) • 5–(2–<br />

IMIDAZOLINYLAMINO)BENZIMIDAZOLE<br />

COMPOUNDS USEFUL AS ALPHA–2<br />

ADRENOCEPTOR AGONISTS<br />

• COMPOSES DE 5–(2–<br />

IMIDAZOLINYLAMINO)BENZIMIDAZOLE<br />

UTILES EN TANT QU’AGONISTES DE<br />

L’ADRENORECEPTEUR ALPHA–2<br />

(71) THE PROCTER & GAMBLE COMPANY<br />

[US/US]; One Procter & Gamble Plaza, Cincinnati,<br />

OH 45202 (US).<br />

(for all designated States except / pour tous les États<br />

désignés sauf US)<br />

(72, 75) CUPPS, Thomas, Lee [US/US]; 193 North<br />

Broad Street, Norwich, NY 13815 (US). BOG-<br />

DAN, Sophie, Eva [US/US]; 714 East Foster–Maineville<br />

Road, Maineville, OH 45039<br />

(US). MIELING, Glen, Edward [US/US]; 7395<br />

Desert Spring Court, West Chester, OH 45069<br />

(US). NIKOLAIDES, Nick [US/US]; 5357<br />

Prescott Court, Mason, OH 45040 (US). HENRY,<br />

Raymond, Todd [US/US]; 877 Hechterman Road,<br />

Pleasant Plain, OH 45162 (US). SHELDON,<br />

Russell, James [US/US]; 5023 Winton Road,<br />

Fairfield, OH 45014 (US).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!